Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 8Carcinoid Tumor 3Acromegaly 3Pituitary Neoplasms 2Neoplasm Metastasis 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma, Hepatocellular 2Pheochromocytoma 1Paraganglioma 1Neoplastic Cells, Circulating 1Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1Gigantism 1Gastrointestinal Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

Blood Specimen Collection 25Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Liquid Biopsy 4cabazitaxel 3Surgical Procedures, Operative 3Propofol 3Carboplatin 3Bevacizumab 3Trastuzumab 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Neoadjuvant Therapy 2Morphine 2Laparoscopy 2Hematologic Tests 2Folfox protocol 2Epirubicin 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Capecitabine 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplastic Cells, Circulating × lanreotide × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡